Coromandel International Ltd

- No explicit mention of any current or future fundraising through debt or equity in the provided transcript. - The company is investing in various projects such as the phosphoric acid expansion (INR ~1,100 crore CAPEX) and MAP plant for specialty nutrients but is not indicating raising funds via equity or debt. - Investments appear to be planned through internal accruals or existing resources. - No references to any capital raising activities, rights issues, or debt issuance were made during the earnings call. - Focus is more on organic growth, capacity expansions, and operational efficiencies rather than fundraising.

- Planned modular investment in TMAP plant with first phase capacity of 25,000 tons; CAPEX INR 150-170 crores. - MAP project at Vizag underway to reduce dependence on imported raw materials, aiding specialty nutrient diversification. - Granulation plant CAPEX ongoing to enhance specialty nutrient portfolio. - Joint venture gypsum project to manufacture Plaster of Paris. - Expansion of Senegal mining operations for rock supply with additional investments to scale from 300,000 to 500,000 tons. - New Phosphoric Acid plant in Kakinada adding 200,000 tons capacity, targeted for 100% utilization by FY27. - Continued debottlenecking capacities in fertilizers and CPC. - Investment in new product registration, capacity creation for active ingredients, and downstream projects for Mancozeb and other molecules to strengthen raw material security. - Exploration of phosphoric acid refinement for battery chemical supply chain with technology readiness expected in six months. - Retail expansion aiming to reach 1,200 stores by FY26 and eventually 2,000 stores.

- Fertilizers: Expanding reach in new Indian markets (UP, Rajasthan, MP), doubling volumes from 100,000 to 200,000 tons in six months, aiming to take at least 1 million tons to market to support new capacity. - Retail footprint growth: Targeting 1,200 stores by year-end, eventually 2,000 stores, increasing presence across key states to boost sales. - Crop Protection: Domestic formulation business expected to grow 25% year-on-year; aims to reach INR 1,000 crores in turnover. - Export crop protection: Focus on molecules like Mancozeb, Boscalid, Pyraoxystrobin, and Malathion with new capacity additions; pipeline of new molecules and contract manufacturing planned over 2-3 years. - Specialty nutrients and bio-products: 20% growth in revenue with diversification into granulation and alternative raw materials to reduce China dependence. - Overall: Crop protection segment, including NACL, targeting revenue of INR 5,000 crores, reinforcing position among top companies in India.

- Phos Acid and Sulfuric Acid expansions with new capacity (7 lakh tons Phos Acid in FY27) expected to sustain at 100% utilization, driving EBITDA growth. - Specialty nutrient business growing strongly (+20% revenue growth) with investments in MAP plant and granulation capacity, enhancing margins. - Crop protection segment, including recent NACL acquisition, expected to cross INR 5,000 crore revenue, expanding profitability. - Crop protection domestic formulations projected 25% annual growth; new product sales contributing 25% share. - Expansion in fertilizer markets (UP, Rajasthan, MP) with volume target increasing from 0.1 to 1 million tons supports top-line growth. - Payback on INR 1,000 crore Phos Acid CAPEX estimated at 2-2.5 years, indicating strong margin improvement. - EBITDA target of minimum INR 5,500 per metric ton maintained, driven by raw material cost management and efficiency gains. - Incremental value creation expected from sulfuric acid integrated production and power generation. - Export crop protection, particularly Mancozeb, showing volume and profitability growth, supporting overall segment expansion.

- Dhaksha is currently focused on new product development and executing defense orders. - Execution of defense orders depends on evaluation of existing prototypes, which is a lengthy process. - The company is actively pursuing government approvals for order clearance. - Once evaluation is complete and orders are confirmed, future order flow is expected to be steady. - Order execution and fresh orders have taken longer than initially anticipated. - No specific numerical data on current orderbook or pending orders was disclosed. - Dhaksha’s other activities include expanding agri-drone services with improving product features and battery life, supported by inputs from Coromandel. - Progress in drone business is ongoing but financial impact is currently limited.